| 标题 |
Inotuzumab ozogamicin versus standard of care in relapsed or refractory acute lymphoblastic leukemia: Final report and long‐term survival follow‐up from the randomized, phase 3 INO‐VATE study |
| 网址 | |
| DOI | |
| 其它 |
期刊:Cancer 作者:Hagop M. Kantarjian; Daniel J. DeAngelo; Matthias Stelljes; Michaela Liedtke; Wendy Stock; et al 出版日期:2019-03-28 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)